Taisho Pharmaceutical Holdings Co., Ltd.
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Taisho Pharmaceutical Holdings Co., Ltd.'s balance sheet done over the years? Its assets were worth $941,490,000,000 last year, which is more than in the previous period. 14% of Taisho Pharmaceutical Holdings Co., Ltd.’s total assets is currently financed by debt. Its liabilities reached the amount of $132,147,000,000, which means an increase by 10% compared compared to last year.
Debt to Assets
| 2014 | 728442000000 | 116.51B | 15.99% |
|---|---|---|---|
| 2015 | 768092000000 | 114.85B | 14.95% |
| 2016 | 759049000000 | 115.92B | 15.27% |
| 2017 | 771222000000 | 106.13B | 13.76% |
| 2018 | 800157000000 | 108.84B | 13.6% |
| 2019 | 821782000000 | 97.64B | 11.88% |
| 2020 | 853051000000 | 111.34B | 13.05% |
| 2021 | 876923000000 | 118.51B | 13.52% |
| 2022 | 888159000000 | 120.20B | 13.53% |
| 2023 | 941490000000 | 132.14B | 14.04% |
TAIPY Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 255.96B | 265.04B | 250.17B | 223.81B | 282.56B | 219.97B | 201.27B | 172.14B | 159.58B | 145.32B |
Short term investments | 200M | 7.21B | 4.01B | 14.08B | 75.9B | 29.73B | -3.16B | 34.31B | 10.03B | 14.08B |
Net receivables | 51.92B | 53.67B | 51.60B | 65.46B | 71.28B | 81.25B | 69.45B | 81.37B | 80.14B | 78.06B |
Inventory | 53.33B | 44.89B | 46.38B | 43.36B | 29.51B | 26.84B | 27.49B | 26.63B | 27.30B | 27.12B |
Other current assets | 14.45B | 8.02B | 5.54B | 8.88B | 10.51B | 4.33B | 10.72B | 5.20B | 11.99B | 16.45B |
Total current assets | 375.88B | 378.86B | 357.73B | 355.62B | 469.78B | 362.14B | 308.94B | 319.67B | 289.08B | 281.04B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 141.17B | 119.29B | 113.19B | 112.55B | 91.28B | 93.71B | 97.28B | 98.95B | 100.36B | 103.58B |
Goodwill | 128.05B | 125.76B | 128.61B | 169.86B | 12.53B | 15.34B | 16.76B | 19.04B | 22.09B | 22.99B |
Intangible assets | 110.44B | 87.29B | 87.92B | 40.11B | 11.76B | 15.76B | 17.60B | 19.81B | 23.15B | 25.78B |
Long term investments | 163.21B | 146.40B | 164.29B | 143.38B | 127.79B | 272.35B | 323.17B | 257.48B | 309.28B | 265.85B |
Other non-current assets | 15.96B | 21.02B | 16.27B | 20.36B | 99.25B | 34.46B | 665M | 36.20B | 18.49B | 21.51B |
Total non-current assets | 565.60B | 509.29B | 519.18B | 497.42B | 351.99B | 438.00B | 462.27B | 439.37B | 479.00B | 447.39B |
Total assets | 941.49B | 888.15B | 876.92B | 853.05B | 821.78B | 800.15B | 771.22B | 759.04B | 768.09B | 728.44B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 209M | 246M | -1.58B | -1.81B | -429M | 0 | 0 | 0 | 0 | 0 |
Short term debt | 1.79B | 2.28B | 1.58B | 1.81B | 429M | 0 | 0 | 0 | 0 | 0 |
Total current liabilities | 73.77B | 62.27B | 57.66B | 66.45B | 58.45B | 60.31B | 58.09B | 66.64B | 64.23B | 76.05B |
| Non-current liabilities: | ||||||||||
Long term debt | 0 | -550M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 25.56B | 28.76B | 28.10B | 27.94B | 25.66B | 31.03B | 31.90B | 32.94B | 31.08B | 26.07B |
Total non-current liabilities | 58.36B | 57.92B | 60.85B | 44.88B | 39.19B | 48.52B | 48.03B | 49.27B | 50.62B | 40.46B |
Total liabilities | 132.14B | 120.20B | 118.51B | 111.34B | 97.64B | 108.84B | 106.13B | 115.92B | 114.85B | 116.51B |